DUBLIN, Sept. 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with a heritage of more than 70 years in eye care, and Molecular Partners (SIX: MOLN), a clinical-stage biotechnology company developing a new class of drugs known as DARPin® platform, today announced that the U.S. Food and Drug Administration (FDA) has accept

NEW HAVEN, Conn., Sept. 9, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced today that it presented expanded data and post-hoc analyses from its long term clinical study (BHV3000-201) demonstrating clinically important benefits of rimegepant on migraine-specific disability and quality of life in the late breaking oral and poster se

COLTS NECK, N.J., Sept. 9, 2019 /PRNewswire/ -- Retro Fitness announced Monday it is donating over 300 New York Yankees tickets to three New York City schools in District 11 as part of the fitness franchise's commitment to giving back to communities.  

CHARLESTON, S.C., Sept. 9, 2019 /PRNewswire/ -- Dr. Patel is a specialist in Urology and Male and Female Genitourinary Reconstructive Surgery in North Carolina and has been in medical practice since 2002. He graduated as Valedictorian and an Alpha Omega Alpha Chair from Wright State University School of Medicin

RA'ANANA, Israel, Sept. 9, 2019 /PRNewswire/ -- MedAware (www.medaware.com) , a developer of AI-based patient safety solutions, today announced that Assuta Ashdod, Israel's newest hospital, will deploy its life-saving AI-driven solution within its 300-bed fac

ST. LOUIS, Sept. 9, 2019 /PRNewswire/ -- Pharmspective LLC announced today the introduction of HealthPlanView™, the first visual analytics platform built to assess the true drug cost burden to patients and payers.

MARLBOROUGH, Mass., Sept. 9, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, announced today that it has entered into a research collaboration with Carisma Therapeutics to evaluate the p

JERUSALEM, Sept. 9, 2019 /PRNewswire/ -- KAHR Medical, a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as DSP (Dual Signaling Proteins), announced today a new clinical collaboration with Roche. The collaboration will explore KAHR's lead program, DSP107, a SIRPα-41

DUBLIN, Sept. 9, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced initial results, including positive biomarker responses, from its Phase 1 single-ascending dose (SAD) and multiple-ascending dose (MAD) clinical trial of TD-8236, an investigational, lung-selective inhaled pan-Janus kinase (JAK) i

MONMOUTH JUNCTION, N.J., Sept. 9, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its